Q4 2025 Holdings
Filed 2026-02-17 | 14 holdings | $762.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $322.7M | 9,198,900 | 42.3% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $106.9M | 5,462,846 | 14.0% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $87.0M | 9,632,561 | 11.4% |
| Rapt Therapeutics Inc(RAPT) | COM NEW | 75382E208 | $62.1M | 1,833,333 | 8.1% |
| Maplight Therapeutics Inc(MPLT) | COM | 56565P103 | $56.7M | 3,226,400 | 7.4% |
| VOR Biopharma Inc(VOR) | COM NEW | 929033207 | $47.3M | 3,617,354 | 6.2% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $27.3M | 2,808,368 | 3.6% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $24.6M | 3,468,430 | 3.2% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $19.9M | 1,677,852 | 2.6% |
| Engene Holdings Inc(ENGNW) | W EXP 10/31/2028 | 29286M113 | $8.5M | 2,878,148 | 1.1% |